Unknown

Dataset Information

0

Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections.


ABSTRACT: A cardinal feature of COVID-19 is lung inflammation and respiratory failure. In a prospective multi-country cohort of COVID-19 patients, we found that increased Notch4 expression on circulating regulatory T (Treg) cells was associated with disease severity, predicted mortality, and declined upon recovery. Deletion of Notch4 in Treg cells or therapy with anti-Notch4 antibodies in conventional and humanized mice normalized the dysregulated innate immunity and rescued disease morbidity and mortality induced by a synthetic analog of viral RNA or by influenza H1N1 virus. Mechanistically, Notch4 suppressed the induction by interleukin-18 of amphiregulin, a cytokine necessary for tissue repair. Protection by Notch4 inhibition was recapitulated by therapy with Amphiregulin and, reciprocally, abrogated by its antagonism. Amphiregulin declined in COVID-19 subjects as a function of disease severity and Notch4 expression. Thus, Notch4 expression on Treg cells dynamically restrains amphiregulin-dependent tissue repair to promote severe lung inflammation, with therapeutic implications for COVID-19 and related infections.

SUBMITTER: Harb H 

PROVIDER: S-EPMC8080416 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2020-11-01 | GSE159584 | GEO
| S-EPMC7578174 | biostudies-literature
| PRJNA669823 | ENA
| S-EPMC7062903 | biostudies-literature
2020-09-01 | GSE151763 | GEO
| S-EPMC4988577 | biostudies-literature
| PRJNA841737 | ENA
| S-EPMC9733946 | biostudies-literature
2022-08-24 | GSE184383 | GEO
| S-EPMC10324174 | biostudies-literature